Insider Transactions in Q1 2025 at Macrogenics Inc (MGNX)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 15
2025
|
James Karrels SVP, CFO and Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
5,790
-3.01%
|
$11,580
$2.56 P/Share
|
|
Feb 15
2025
|
James Karrels SVP, CFO and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
14,998
+7.22%
|
-
|
|
Feb 15
2025
|
Ezio Bonvini Sr VP, Research & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,665
+11.81%
|
-
|
|
Feb 15
2025
|
Jeffrey Stuart Peters Senior VP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
5,147
-27.29%
|
$10,294
$2.56 P/Share
|
|
Feb 15
2025
|
Jeffrey Stuart Peters Senior VP and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
13,332
+41.42%
|
-
|
|
Feb 15
2025
|
Scott Koenig President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
42,329
+5.16%
|
-
|
|
Feb 15
2025
|
Stephen L. Eck Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,942
-14.4%
|
$9,884
$2.56 P/Share
|
|
Feb 15
2025
|
Stephen L. Eck Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,665
+32.69%
|
-
|
|
Feb 15
2025
|
Thomas Spitznagel Sr VP, Technical Ops |
SELL
Payment of exercise price or tax liability
|
Direct |
5,520
-20.5%
|
$11,040
$2.56 P/Share
|
|
Feb 15
2025
|
Thomas Spitznagel Sr VP, Technical Ops |
BUY
Exercise of conversion of derivative security
|
Direct |
13,332
+33.12%
|
-
|
|
Feb 15
2025
|
Beth Ann Smith VP, Controller & Treasurer |
SELL
Open market or private sale
|
Direct |
423
-4.25%
|
$846
$2.56 P/Share
|
|
Feb 15
2025
|
Beth Ann Smith VP, Controller & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,095
+9.91%
|
-
|
|
Feb 15
2025
|
Eric Blasius Risser Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,433
-10.31%
|
$12,866
$2.56 P/Share
|
|
Feb 15
2025
|
Eric Blasius Risser Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,665
+21.07%
|
-
|
|
Feb 08
2025
|
James Karrels SVP, CFO and Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
3,861
-2.13%
|
$7,722
$2.6 P/Share
|
|
Feb 08
2025
|
James Karrels SVP, CFO and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
10,002
+5.22%
|
-
|
|
Feb 08
2025
|
Eric Blasius Risser Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,311
-8.61%
|
$8,622
$2.6 P/Share
|
|
Feb 08
2025
|
Eric Blasius Risser Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,168
+18.24%
|
-
|
|
Feb 08
2025
|
Ezio Bonvini Sr VP, Research & CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,311
-3.85%
|
$8,622
$2.6 P/Share
|
|
Feb 08
2025
|
Ezio Bonvini Sr VP, Research & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,168
+9.06%
|
-
|
|
Feb 08
2025
|
Stephen L. Eck Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,312
-15.8%
|
$6,624
$2.6 P/Share
|
|
Feb 08
2025
|
Stephen L. Eck Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,168
+34.75%
|
-
|
|
Feb 08
2025
|
Scott Koenig President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
31,673
+4.13%
|
-
|
|
Feb 08
2025
|
Beth Ann Smith VP, Controller & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
612
-6.46%
|
$1,224
$2.6 P/Share
|
|
Feb 08
2025
|
Beth Ann Smith VP, Controller & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,583
+14.32%
|
-
|
|
Feb 08
2025
|
Thomas Spitznagel Sr VP, Technical Ops |
SELL
Payment of exercise price or tax liability
|
Direct |
3,727
-21.52%
|
$7,454
$2.6 P/Share
|
|
Feb 08
2025
|
Thomas Spitznagel Sr VP, Technical Ops |
BUY
Exercise of conversion of derivative security
|
Direct |
9,001
+34.2%
|
-
|
|
Feb 08
2025
|
Jeffrey Stuart Peters Senior VP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
3,475
-38.61%
|
$6,950
$2.6 P/Share
|
|
Feb 08
2025
|
Jeffrey Stuart Peters Senior VP and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
9,001
+50.0%
|
-
|